Our preoccupation with coronary luminology: The dissociation between clinical and angiographic findings in ischemic heart disease

Circulation

Volumn 92, Issue 8, 1995, Pages 2333-2342

  Topol, Eric J ^a   Nissen, Steven E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

angiography; angioplasty; atherosclerosis; myocardial infarction; revascularization

Indexed keywords

ANGIOCARDIOGRAPHY; BLOOD VESSEL DIAMETER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART MUSCLE ISCHEMIA; IMAGE ANALYSIS; IMAGE QUALITY; OBSERVER VARIATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0028876102     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.92.8.2333     Document Type: Review

References (86)

1. Sones FM, Shirey EK. Cine coronary arteriography. Mod Concepts Cardiovasc Dis. 1962;31:735-738.
2. Graves EJ. Detailed diagnoses and procedures: National Hospital Survey 1990. Washington, DC: National Center for Health Statistics Vital Health Stat 13(113); 1992.
3. Rensing BJ, Hermans WRM, Deckers JW, de Feyter PJ, Tijssen JGP, Serruys PW. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1,445 successfully dilated lesions. J Am Coll Cardiol. 1992;19:939-945.
4. Kuntz RE, Safian RD, Levine MJ, Reis GJ, Diver DJ, Baim DS. Novel approach to the analysis of restenosis after the use of three new coronary devices. J Am Coll Cardiol. 1992;19:1493-1499.
5. Kuntz RE, Safian RD, Carrozza JP, Fishman RF, Mansour M, Baim DS. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation. 1992;86:1827-1835.
6. Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW. Interobserver variability in coronary angiography. Circulation. 1976; 53:627-632.
7. Galbraith JE, Murphy ML, Desoyza N. Coronary angiogram interpretation: interobserver variability. JAMA. 1981;240:2053-2059.
8. Arnett EN, Isner JM, Redwood CR, Kent KM, Baker WP, Ackerstein H, Roberts WC. Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med. 1979;91:350-356.
9. Grodin CM, Dyrda I, Pasternac A, Campeu L, Bourassa MG. Discrepancies between cineangiographic and post-mortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation. 1974;49:703-709.
10. Blankenhorn DH, Curry PJ. The accuracy of arteriography and ultrasound imaging for atherosclerosis measurement: a review. Arch Pathol Lab Med. 1982;106:483-490.
11. Isner JM, Kishel J, Kent KM. Accuracy of angiographic determination of left main coronary arterial narrowing. Circulation. 1981; 63:1056-1061.
12. Roberts WC, Jones AA. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death. Am J Cardiol. 1979; 44:39-44.
13. Vlaodaver Z, French R, van Tassel RA, Edwards JE. Correlation of the antemortem coronary angiogram and the postmortem specimen. Circulation. 1973;47:162-168.
14. White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, Marcus ML. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med. 1984;310:819-824.
15. Kern MJ, Donohue TJ, Aguirre FV, Bach RG, Caracciolo EA, Ofili E, Labovitz AJ. Assessment of angiographically intermediate coronary artery stenoses using the Doppler flow wire. Am J Cardiol. 1993;71:26D-33D.
16. Waller BF. 'Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders, and melters': the future treatment of atherosclerotic coronary artery disease? A clinical-morphologic assessment. J Am Coll Cardiol. 1989;13:969-987.
17. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human coronary arteries. N Engl J Med. 1987;316:1371-1375.
18. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, Santamore WP. Can arteriography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78: 1157-1166.
19. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments by intravascular ultrasound. J Am Coll Cardiol. 1994;23:352-357.
20. Nissen SE. Radiographic principles in cardiac catheterization. In: Roubin GS, Califf RM, O'Neill W, Phillips H, Stack R, eds. Interventional Cardiac Catheterization: Principles and Practice. New York, NY: Churchill Livingstone Inc; 1993:409-425.
21. Nissen SE, Tuzcu EM, DeFranco AC, Moliterno D. Evaluation of stenosis severity: quantitative angiography, coronary flow reserve, and intravascular ultrasound. In: Ellis SG, Holmes D, eds. Strategic Approaches to Coronary Intervention. Baltimore, MD: Williams & Wilkins; 1995. In press.
22. Elliot J, Tuzcu EM, Guyer S, Lefkovits J, DeFranco AC, Nissen SE. Relationship of left main coronary dimension to branch vessel size: a new index for detection of left main coronary artery disease. J Am Coll Cardiol. 1994;23:210A. Abstract.
23. DeFranco AC, Tuzcu M, Eaton G, Raymond RE, Franco I, Guyer A, Nissen SE. Detection of unrecognized LMCA disease by intravascular ultrasound in patients undergoing interventions: prevalence and severity. Circulation. 1993;88(pt 2):I-411. Abstract.
24. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33:87-93.
25. Vogel RA, LeFree MT, Bates ER, O'Neil WW, Foster R, Kirklin P, Smith D, Pitt B. Application of digital techniques to selective coronary arteriography: use of myocardial appearance time to measure coronary flow reserve. Am Heart J. 1983;107:153-164.
26. Nissen SE, Elion JL, Booth DC. Value and limitations of computer analysis of digital subtraction angiography in the assessment of coronary flow reserve. Circulation. 1986;73:562-571.
27. Brown BG, Bolson E, Frimer M, Dodge HT. Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriograms and digital computation. Circulation. 1977;55:329-337.
28. Gurley JC, Nissen SE, Booth DC, Harrison M, DeMaria AN. Influence of operator and patient-dependent variables on the suitability of automated coronary arteriography. J Am Coll Cardiol. 1992;19:1237-1243.
29. Keane D, Haase J, Slager CJ, van Swijndregt E, Lehmann KG, Ozaki Y, Di Mario C, Kirkeeide R, Serruys PW. Comparative validation of quantitative coronary angiography systems. Circulation. 1995;91: 2174-2183.
30. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, Lee KL, Pitt B, Stack RS, O'Neill WW, and the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987;317:581-588.
31. TIMI Research Group. Immediate versus delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction: TIMI IIa results. JAMA. 1988;260:2849-2858.
32. Simoons ML, Arnold AER, Betriu A, deBono DP, Col J, Dougherty FC, von Essen R, Lambertz H, Lubsen J, Meier B, Michel PL, Raynaud P, Rutsch W, Sanz GA, Schmidt W, Serruys PW, Thery C, Uebis R, Vahanian A, Van de Werf F, Willems GM, Wood D, Verstraete M. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous transluminal coronary angioplasty. Lancet. 1988;1:197-203.
33. TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. N Engl J Med. 1989; 320:618-627.
34. SWIFT Trial Study Group. SWIFT trial of delayed elective intervention versus conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. Br Med J. 1991;302:555-560.
35. Ellis SG, Topol EJ, George BS, Kereiakes DJ, Debowey D, Sigmon KN, Pickel A, Lee KL, Califf RM. Recurrent ischemia without warning: analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. Circulation. 1989;80:1159-1165.
36. Reiner JS, Lundergan CF, van den Brand M, Boland J, Thompson MA, Machecourt J, Py A, Pilcher GS, Fink CA, Burton JR, Simoons ML, Califf RM, Topol EJ, Ross AM, for the GUSTO Angiographic Investigators. Early angiography cannot predict post-thrombotic coronary reocclusion: observations from the GUSTO Angiographic Study. J Am Coll Cardiol. 1994;24:1439-1444.
37. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:1699-1705.
38. Topol EJ. Coronary angioplasty for acute myocardial infarction. Ann Intern Med. 1988;109:970-980.
39. ACC/AHA Task Force Report. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol. 1988;12:529-545.
40. Sutton JM, Topol EJ. Significance of a negative exercise thallium test in the presence of a critical residual stenosis after thrombolysis for acute myocardial infarction. Circulation. 1991;83:1278-1286.
41. Ellis SG, Mooney MR, George BS, Ribeiro da Silva EE, Talley JD, Flanagan WH, Topol EJ. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Circulation. 1992;86:1400-1406.
42. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, Knight JD, Nelson CL, Lee KL, Clapp-Channing N, Sutherland W, Pilote L, Armstrong P. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 1994;331:1130-1135.
43. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, Rubison RM, Tiefenbrunn AJ, Weaver WD. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 1994;90:2103-2114.
44. Topol EJ, Ellis SG, Cosgrove DM, Bates ER, Muller DWM, Schork N, Schork MA, Loop FD, Analysis of coronary angioplasty practice in the United States using a private insurance database. Circulation. 1993;87:1489-1497.
45. Simpson JB. How atherectomy began: a personal history. Am J Cardiol. 1993;72:3E-5E.
46. Bairn DS, Hinohara T, Holmes D, Topol E, Pinkerton C, King SB III, Whitlow P, Kereiakes D, Parley B, Simpson JB. Results of directional coronary atherectomy during multicenter preapproval testing. Am J Cardiol. 1993;72:6E-11E.
47. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hofling B, Simonton CA, Masden RR, Serruys PW, Leon MB, Williams DO, King B, Mark DB, Isner JM, Holmes DR, Ellis SG, Lee KL, Keeler G, Berdan LG, Hinohara T, Califf RM, on behalf of the CAVEAT Study Group. A comparison of coronary angioplasty with directional atherectomy in patients with coronary artery disease. N Engl J Med. 1993;329:221-227.
48. Elliott JM, Berdan LG, Holmes DR, Isner JM, King SB, Keeler GP, Kearney M, Califf RM, Topol EJ, for the CAVEAT Study Investigators. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-1). Circulation. 1995;91:2158-2166.
49. Muller DWM, Ellis SG, Debowey DL, Topol EJ. Quantitative angiographic comparison of the immediate success of coronary angioplasty, coronary atherectomy and endoluminal stenting. Am J Cardiol. 1990;66:796-801.
50. Adelman AG, Cohen EA, Kimball BP, Bonan R, Ricci DR, Webb JG, Laramee L, Barbeau G, Traboulsi M, Corbett BN, Schwartz L, Logan AG. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med. 1993;329:228-233.
51. Umans VAWM, Keane D, Foley D, Boersma E, Melkert R, Serruys PW. Optimal use of directional coronary atherectomy is required to ensure long-term angiographie benefit: a study with matched procedural outcome after atherectomy and angioplasty. J Am Coll Cardiol. 1994;24:1652-1659.
52. Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuclsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA, for the BENESTENT Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
53. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish D, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331: 496-501.
54. 53a.Lemaitre DT, Barber AP, Mullen MG, Luft H. Interventional cardiology. In: Industry Strategies. Boston, Mass: Cowen & Co; February 22, 1995.
55. Topol EJ. Caveats about elective coronary stenting. N Engl J Med. 1994;331:539-541.
56. Goldberg SL, Colombo A, Nakamura S, Almagor Y, Maiello L, Tobis JM. Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents. J Am Coll Cardiol. 1994;24:996-1003.
57. Colombo A, Goldberg SL, Almagor Y, Maiello L, Finci L. A novel strategy for stent deployment in the treatment of acute or threatened closure complicating balloon coronary angioplasty. J Am Coll Cardiol. 1993;22:1887-1891.
58. Colombo A, Hall P, Martini G. Stenting with echo guidance but without anticoagulation. In: Current Review of Interventional Cardiology. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1995:115-133.
59. The ACCORD Study Investigators. Nitric oxide donors reduce restenosis after coronary angioplasty: the ACCORD Study. J Am Coll Cardiol. 1994;23:59A. Abstract.
60. Emanuelsson H, Beatt KJ, Bagger JP, Balcon R, Heikkila J, Piessens J, Schaeffer M, Suryapranata H, Feogh M, for the European Angiopeptin Study Group. Long-term effects of angiopeptin treatment in coronary angioplasty. Circulation. 1995;91: 1689-1696.
61. Folland ED, Vogel RA, Hartigan P, Bates ER, Beauman GJ, Fortin T, Boucher C, Parisi AF, Veterans Affairs ACME Investigators. Relation between coronary artery stenosis assessed by visual, caliper, and computer methods and exercise capacity in patients with single-vessel coronary artery disease. Circulation. 1994;89: 2005-2014.
62. Holmes DR, Topol EJ, Califf RM, Leya F, Berberg PB, Talley JD, Kellett MA, Shani J, Gottlieb RS, Whitlow PL, Adelman AG, Pinkerton CA, Lee KL, Pieper K, Keeler GP, Ellis SG, for the CAVEAT-II Investigators. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation. 1995;91:1966-1974.
63. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events. Br Heart J. 1993;69:S48-S53.
64. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study. Lancet. 1994;344: 1383-1389.
65. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993;87: 1781-1790.
66. Fuster V. Lewis A. Conner Memorial Lecture: mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994;90:2126-2146.
67. Davies MJ, Kriklcr DM, Katz D. Atherosclerosis: inhibition or regression as therapeutic possibilities. Br Heart J. 1991;65:302-310.
68. MacIsaac AI, Thomas JD, Topol EJ. Toward the quiescent coronary plaque. J Am Coll Cardiol. 1993;22:1228-1241.
69. Peterson MD, Abe T, Morgan DA, Gutterman DD. Role of adenosine in postischemic dysfunction of coronary innervation. Circ Res. 1995;76:76-95.
70. Nissen SE, Gurley JC. Application of intravascular ultrasound to detection and quantitation of coronary atherosclerosis. Int J Cardiac Imaging. 1991;6:165-177.
71. Nissen SE, Grines CL, Gurley JC, Sublett K, Haynie D, Diaz C, Booth DC, DeMaria AN. Application of a new phased-array ultrasound catheter in the assessment of vascular dimensions: in-vivo comparison to cineangiography. Circulation. 1990;82: 660-666.
72. Nissen SE, Gurley CL. Assessment of coronary angioplasty results by intravascular ultrasound. In: Serruys PW, Strauss BH, King SB, eds. Restenosis After Intervention With New Mechanical Devices. Dordrecht, Netherlands: Kluwer Academic Publishers; 1992:73-96.
73. DeFranco AC, Tuzcu E, Abdelmeguid A, Lincoff AM, Brown D, Bernardi M, Ellis SG, Whitlow PL, Sutton JM, Casale PM, Raymond RE, Topol EJ, Nissen SE. Intravascular ultrasound assessment of PTCA results: insights into the mechanisms of balloon angioplasty. J Am Coll Cardiol. 1993;21:485A. Abstract.
74. Tobis JM, Mallery J, Mahon D, Lehmann K, Zalesky P, Griffith J, Gessert J, Moriuchi M, McRae M, Dwyer ML, Greep N, Henry WL. Intravascular ultrasound imaging of human coronary arteries in vivo. Circulation. 1991;83:913-926.
75. DeFranco AC, Tuzcu EM, Moliterno DJ, Elliott J, Berkalp B, Franco I, Raymond RE, Whitlow PL, Guyer S, Nissen SE. Over-estimation of lumen size after coronary interventions: implications for randomized trials of new devices. Circulation. 1994;90(pt 2):I-550. Abstract.
76. Berkalp B, Nissen SE, DeFranco AC, Moliterno DJ, Franco I, Raymond RE, Sutton J, Guyer S, Tuzcu EM. Intravascular ultrasound demonstrates marked differences in lumen shape following interventional devices. Circulation. 1994;90(pt 2):I-58. Abstract.
77. Tuzcu EM, Hobbs H, Rincon G, Bott-Silverman C, DeFranco AC, Robinson K, McCarthy P, Stewart R, Guyer S, Nissen SE. Occult and frequent transmission of atherosclerosis coronary disease with cardiac transplantation. Circulation. 1995;91:1706-1713.
78. Pratt CM, Move LA. The Cardiac Arrhythmia Suppression Trial: casting suppression in a different light. Circulation. 1995;91:245-247.
79. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, De Mats DL, for the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325: 1468-1475.
80. The GUSTO IIa Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation. 1994;90:1631-1637.
81. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
82. The GUSTO Angiographic Investigators. The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615-1622.
83. Simes RJ, Topol EJ, Holmes DR, White HD, Rutsch WR, Vahanian A, Simoons ML, Morris D, Betriu A, Califf RM, Ross AM. for the GUSTO Investigators. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: the importance of early and complete infarct artery reperfusion. Circulation. 1995;91:1923-1928.
84. Lefkovits J, Plow EF, Topol EJ. The use of platelet glycoprotein IIb/IIIa receptor inhibitors in cardiovascular medicine. N Engl J Med. 1995;332:1553-1559.
85. Skinner MP, Yuan C, Mitsumori L, Hayes CE, Raines EW, Nelson JA, Ross R. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nature Med. 1995;1:69-73.
86. Libby P. Lesion versus lumen. Nat Med. 1995;1:17-18.